February 5, 2010
View Full PaperValidation of claims‐based diagnostic and procedure codes for cardiovascular and gastrointestinal serious adverse events in a commercially‐insured population
Structured PICO
P
Population
Commercially-insured population in the US
I
Intervention
Claims-based diagnostic and procedure codes
O
Outcome
Validation of codes for cardiovascular and gastrointestinal serious adverse events
Claims-based diagnostic and procedure codes are valid for identifying certain cardiovascular and gastrointestinal serious adverse events in pharmacoepidemiology research.
Abstract
The results suggest that, for certain adverse events, claims data can serve as the basis for pharmacoepidemiology research and drug safety surveillance in the US.